GDMV star enterprise- Baisheng Biotechnology (Guangzhou) , as a professional pathological equipment and reagent supplier, in order to cooperate with the national measures to combat new coronary pneumonia, resume work and put into production ahead of schedule, and actively prepare antibodies required for pathological research of new coronary pneumonia Reagents are willing to provide HLA-DR antibodies and CD38 antibodies for free to scientific research institutes and hospitals nationwide that conduct related pathological research. According to the research progress of pathological anatomy, relevant reagents will be prepared as soon as possible.

GDMV Nansha Incubator actively responds to the requirements of relevant government documents at all levels on epidemic prevention and control work, implements various prevention and control measures, spares no effort to ensure the health and safety of enterprises and employees in the incubator, and makes relevant arrangements for the resumption of work and production, and to help enterprises resume work and production safely and efficiently.

疫情就是命令，防控就是责任。新型冠状病毒感染的肺炎疫情牵动着所有人的心。一方有难，八方支援，面对来势汹汹的疫情，广东医谷园区企业快速响应，发挥专长，积极投入这场疫情防控阻击战。

In order to deeply understand the development status of enterprises in GDMV and solve the problems encountered by the enterprises in the incubator, Zhujiang Street "Government and enterprises work together to promote development | Key Enterprise Symposium of GDMV Nansha Incubator " was successfully held in GDMV Nansha Incubator on January 7, 2020.